Search results
Results From The WOW.Com Content Network
Before being spun off, Baxalta acquired SuppreMol (a German company) for US$225 million. [4] Baxalta also acquired the blockbuster leukemia drug Oncaspar from Sigma-Tau Finanziaria S.p.A. for US$900 million. [1] [5] In August 2015, Shire Plc made an unsolicited $30.6 billion stock offer for the company [6] [7] increasing the Baxalta share price ...
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. [ 2] The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products.
Shire plc. Shire plc was a UK -founded Jersey -registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.
After Berkshire's 13-F filing in May showed that the company had sold more than 116 million shares of Apple, cutting its stake by 13%, Buffett addressed the move at the annual shareholder meeting ...
The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson.It later moved its headquarters to New Jersey. In 2004, BD agreed to pay out US$100 million to settle allegations from competitor Retractable Technologies that it had engaged in anti-competitive behavior to prevent the distribution of Retractable's syringes, which are designed to prevent needlestick ...
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Kawa was specifically referencing Tuesday's price action, in which the S&P 500 managed a 0.4% gain despite 384 of its components closing in the red — a new feat for a data set that goes back to ...
Takeda Midosuji Building, headquarters of Takeda Pharmaceutical Company, in Chuo-ku, Osaka, Japan. Takeda Pharmaceuticals was founded in 1781, and was incorporated on January 29, 1925. [ 12] One of the firm's mainstay drugs is Actos ( pioglitazone ), a compound in the thiazolidinedione class of drugs used in the treatment of type 2 diabetes.